Olivia Petter, The Independent If someone had told my teenage self that a magical drug would make me thin, I’d have taken it ...
Semaglutide (Ozempic) is 1 of 15 medications that will be included in yearly price negotiations between Medicare and ...
The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...
Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...
The list includes Novo Nordisk’s blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, ...
GlobalData analysts are predicting an Alzheimer’s disease market boom, tipping its value across major regions to increase ...
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of federal price negotiations, which are scheduled to begin this year, with ...
Eli Lilly (LLY 1.45%) began a roll in late 2020 that lasted almost four years. During that time, it became the world's ...
Olivia Petter talks to experts who say that people with eating disorders are especially vulnerable to the allure of ‘quick fix’ slimming with diabetes drug semaglutide... and are not thinking about it ...
Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...
During JPM week, virtual care companies strut their plans to make GLP-1 drugs work harder, cost less
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...
I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback